|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| License | |||||
| Royalty | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Research and development, net | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of intangible assets | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Financial income, net | |||||
| Remeasurement of marketable equity securities | |||||
| Loss before taxes on income | |||||
| Taxes on income | |||||
| Net loss from continuing operations | |||||
| Net Income from discontinued operations | |||||
| Net loss | |||||
| Basic net income (loss) per share: | |||||
| From continuing operations (in dollars per share) | |||||
| From discontinued operations (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Weighted average shares used to compute net income (loss) per share (in thousands): | |||||
| Basic and diluted (in shares) | |||||
| Diluted (in shares) | |||||
| From continuing operations (in dollars per share) | |||||
| Diluted net income (loss) per share: | |||||
| From continuing operations (in dollars per share) | |||||
| From discontinued operations (in dollars per share) |
Loading...